The U.S. Department of Health and Human Services is looking for vendor information to fill new drug products as it continues its efforts to combat the recent Ebola epidemic in West Africa.
Issued on Friday, the Request for Information seeks to find companies capable of formulating, filling and finishing new drug products. While a vaccine for Ebola has not been produced, the department is asking companies for their capabilities to reproduce experimental vaccines.
The new products are Live Vectored Vaccines (LVV), the department said. The products are in the early development stage. They will likely have limited stability data and will need to be kept at very low temperatures.
The department is seeking information on companies' capability of producing two similar experimental Ebola vaccines. The drug substances are currently being developed and manufactured to support the LVV products. Companies would be required to formulate the product in order to set the right concentration.
Applications are strictly for information purposes, and the department said this is not a request for proposals. The final concentrations will be provided by the government, and release of the drug will be performed by the owner of the formula.
Companies have until Dec. 1 to submit their capability packages to the department.